Effect of clopidogrel pretreatment on ischemic complications of percutaneous coronary intervention among bivalirudin-treated patients (from the EVENT registry)

American Journal of Cardiology

Volumn 107, Issue 12, 2011, Pages 1751-1756

  Amin, Amit P ^a,b   Kennedy, Kevin F ^a   Pencina, Michael ^c   Berger, Peter ^d   Piana, Robert N ^e   Lopez, John ^f   Kleiman, Neal ^g   Cohen, David J ^a  

^a Saint Luke's Mid America Heart and Vascular Institute   (United States)

^b UNIVERSITY OF MISSOURI KANSAS CITY   (United States)

^c Boston University   (United States)

^d GEISINGER MEDICAL CENTER   (United States)

^e VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^f LOYOLA UNIVERSITY CHICAGO   (United States)

^g HOUSTON METHODIST RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLOPIDOGREL; HIRULOG;

AGED; ANTICOAGULANT THERAPY; BLEEDING; CONFERENCE PAPER; DISEASE ASSOCIATION; DRUG EFFECT; DRUG FATALITY; FEMALE; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MORTALITY; OBSERVATIONAL STUDY; PERCUTANEOUS CORONARY INTERVENTION; PREMEDICATION; PRIORITY JOURNAL; REGISTER; STENT THROMBOSIS; UNITED STATES;

ACUTE CORONARY SYNDROME; AGED; ANGIOPLASTY, BALLOON, CORONARY; ANTITHROMBINS; FEMALE; HEMORRHAGE; HIRUDINS; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PEPTIDE FRAGMENTS; PLATELET AGGREGATION INHIBITORS; PREMEDICATION; RECOMBINANT PROTEINS; THROMBOSIS; TICLOPIDINE;

EID: 79957955953     PISSN: 00029149     EISSN: 18791913     Source Type: Journal    
DOI: 10.1016/j.amjcard.2011.02.331     Document Type: Conference Paper

References (27)

1. S.R. Steinhubl, P.B. Berger, J.T. Mann III, E.T. Fry, A. DeLago, C. Wilmer, and E.J. Topol Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial JAMA 288 2002 2411 2420 (Pubitemid 35340537)
2. S.R. Mehta, S. Yusuf, R.J. Peters, M.E. Bertrand, B.S. Lewis, M.K. Natarajan, K. Malmberg, H. Rupprecht, F. Zhao, S. Chrolavicius, I. Copland, and K.A. Fox Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study Lancet 358 2001 527 533 (Pubitemid 32772726)
3. M.S. Sabatine, C.P. Cannon, C.M. Gibson, J.L. Lopez-Sendon, G. Montalescot, P. Theroux, B.S. Lewis, S.A. Murphy, C.H. McCabe, and E. Braunwald Effect of clopidogrel pretreatment before percutaneous coronary intervention in patients with ST-elevation myocardial infarction treated with fibrinolytics: the PCI-CLARITY study JAMA 294 2005 1224 1232 (Pubitemid 41352110)
4. M.S. Sabatine, H.N. Hamdalla, S.R. Mehta, K.A. Fox, E.J. Topol, S.R. Steinhubl, and C.P. Cannon Efficacy and safety of clopidogrel pretreatment before percutaneous coronary intervention with and without glycoprotein IIb/IIIa inhibitor use Am Heart J 155 2008 910 917
5. S.X. Anand, M.C. Kim, M. Kamran, S.K. Sharma, A.S. Kini, J. Fareed, D.A. Hoppensteadt, F. Carbon, E. Cavusoglu, D. Varon, J.F. Viles-Gonzalez, J.J. Badimon, and J.D. Marmur Comparison of platelet function and morphology in patients undergoing percutaneous coronary intervention receiving bivalirudin versus unfractionated heparin versus clopidogrel pretreatment and bivalirudin Am J Cardiol 100 2007 417 424 (Pubitemid 47094690)
6. J.F. Saucedo, W. Aude, R. Pacheco, B. Thorn, Z. Matin, K. Husain, and L. Garza Inhibition of platelet aggregation with eptifibatide, bivalirudin, and heparin in patients undergoing percutaneous coronary intervention receiving clopidogrel pretreatment (The PharmacoDynamic Evaluation of Angiomax, clopidogrel with or without Integrilin [DEACON] study) Am J Cardiol 95 2005 1453 1456 (Pubitemid 40824766)
7. D. Sibbing, G. Busch, S. Braun, S. Jawansky, A. Schomig, A. Kastrati, I. Ott, and B.N. von Impact of bivalirudin or unfractionated heparin on platelet aggregation in patients pretreated with 600 mg clopidogrel undergoing elective percutaneous coronary intervention Eur Heart J 29 2008 1504 1509 (Pubitemid 351881984)
8. S. Jacob, D.J. Cohen, J. Massaro, P. Niemyski, K. Maresh, and N. Kleiman Design of a registry to characterize "real-world" outcomes of percutaneous coronary revascularization in the drug-eluting stent era Am Heart J 150 2005 887 892 (Pubitemid 41607758)
9. G. Montalescot, G. Sideris, C. Meuleman, C. Bal-dit-Sollier, N. Lellouche, P.G. Steg, M. Slama, O. Milleron, J.P. Collet, P. Henry, F. Beygui, and L. Drouet A randomized comparison of high clopidogrel loading doses in patients with nonST-segment elevation acute coronary syndromes: the ALBION (Assessment of the Best Loading Dose of clopidogrel to Blunt Platelet Activation, Inflammation and Ongoing Necrosis) trial J Am Coll Cardiol 48 2006 931 938 (Pubitemid 44292463)
10. G. Patti, G. Colonna, V. Pasceri, L.L. Pepe, A. Montinaro, and S.G. Di Randomized trial of high loading dose of clopidogrel for reduction of periprocedural myocardial infarction in patients undergoing coronary intervention: results from the ARMYDA-2 (Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty) study Circulation 111 2005 2099 2106 (Pubitemid 40577905)
11. J.H. Chesebro, G. Knatterud, R. Roberts, J. Borer, L.S. Cohen, J. Dalen, H.T. Dodge, C.K. Francis, D. Hillis, and P. Ludbrook Thrombolysis In Myocardial Infarction (TIMI) Trial, phase I: a comparison between intravenous tissue plasminogen activator and intravenous streptokinase Clinical findings through hospital discharge Circulation 76 1987 142 154 (Pubitemid 17093202)
12. D.E. Cutlip, S. Windecker, R. Mehran, A. Boam, D.J. Cohen, G.-A. van Es, P. Gabriel Steg, M.-a. Morel, L. Mauri, P. Vranckx, E. McFadden, A. Lansky, M. Hamon, M.W. Krucoff, P.W. Serruys Academic Research Consortium Clinical end points in Coronary stent Trials: A Case for Standardized Definitions Circulation 115 2007 2344 2351 (Pubitemid 46685903)
13. K. Larsen, and J. Merlo Appropriate assessment of neighborhood effects on individual health: integrating random and fixed effects in multilevel logistic regression Am J Epidemiol 161 2005 81 88 (Pubitemid 40053282)
14. K. Larsen, J.H. Petersen, E. Budtz-Jorgensen, and L. Endahl Interpreting parameters in the logistic regression model with random effects Biometrics 56 2000 909 914
15. P.R. Rosenbaum, and D.B. Rubin The central role of the propensity score in observational studies for causal effects Biometrika 70 1983 41 55
16. A.S. Levey, J. Coresh, T. Greene, L.A. Stevens, Y.L. Zhang, S. Hendriksen, J.W. Kusek, and F. Van Lente Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate Ann Intern Med 145 2006 247 254 (Pubitemid 46768608)
17. P.C. Austin Goodness-of-fit diagnostics for the propensity score model when estimating treatment effects using covariate adjustment with the propensity score Pharmacoepidemiol Drug Saf 17 2008 1202 1217
18. P.C. Austin Using the standardized difference to compare the prevalence of a binary variable between two groups in observational research Commun Stat-Simul Comput 38 2009 1228 1234
19. J. Saw, A.M. Lincoff, W. Desmet, A. Betriu, W. Rutsch, R.G. Wilcox, N.S. Kleiman, K. Wolski, and E.J. Topol Lack of clopidogrel pretreatment effect on the relative efficacy of bivalirudin with provisional glycoprotein IIb/IIIa blockade compared to heparin with routine glycoprotein IIb/IIIa blockade: a REPLACE-2 substudy J Am Coll Cardiol 44 2004 1194 1199 (Pubitemid 39208873)
20. A.M. Lincoff, S.R. Steinhubl, S.V. Manoukian, D. Chew, C.V. Pollack Jr, F. Feit, J.H. Ware, M.E. Bertrand, E.M. Ohman, W. Desmet, D.A. Cox, R. Mehran, and G.W. Stone Influence of timing of clopidogrel treatment on the efficacy and safety of bivalirudin in patients with non-ST-segment elevation acute coronary syndromes undergoing percutaneous coronary intervention: an analysis of the ACUITY (Acute Catheterization and Urgent Intervention Triage strategY) trial JACCcardiovasc Interv 1 2008 639 648
21. G.W. Stone, B.T. McLaurin, D.A. Cox, M.E. Bertrand, A.M. Lincoff, J.W. Moses, H.D. White, S.J. Pocock, J.H. Ware, F. Feit, A. Colombo, P.E. Aylward, A.R. Cequier, H. Darius, W. Desmet, R. Ebrahimi, M. Hamon, L.H. Rasmussen, H.J. Rupprecht, J. Hoekstra, R. Mehran, and E.M. Ohman Bivalirudin for patients with acute coronary syndromes N Engl J Med 355 2006 2203 2216 (Pubitemid 44791162)
22. G. Di Sciascio, G. Patti, V. Pasceri, L. Gatto, G. Colonna, and A. Montinaro Effectiveness of in-laboratory high-dose clopidogrel loading versus routine pre-load in patients undergoing percutaneous coronary intervention: results of the ARMYDA-5 preload (Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty) randomized trial J Am Coll Cardiol 56 2010 550 557
23. Z. Xiao, and P. Theroux Platelet activation with unfractionated heparin at therapeutic concentrations and comparisons with a low-molecular-weight heparin and with a direct thrombin inhibitor Circulation 97 1998 251 256 (Pubitemid 28067310)
24. EPISTENT Investigators Randomised placebo-controlled and balloon-angioplasty-controlled trial to assess safety of coronary stenting with use of platelet glycoprotein-IIb/IIIa blockade Lancet 352 1998 87 92
25. J.C. O'Shea, G.E. Hafley, S. Greenberg, V. Hasselblad, T.J. Lorenz, M.M. Kitt, J. Strony, and J.E. Tcheng Platelet glycoprotein IIb/IIIa integrin blockade with eptifibatide in coronary stent intervention: the ESPRIT trial: a randomized controlled trial JAMA 285 2001 2468 2473 (Pubitemid 32433840)
26. P. Widimsky, Z. Motovska, S. Simek, P. Kala, R. Pudil, F. Holm, R. Petr, D. Bilkova, H. Skalicka, P. Kuchynka, M. Poloczek, R. Miklik, M. Maly, and M. Aschermann Clopidogrel pre-treatment in stable angina: for all patients >6 h before elective coronary angiography or only for angiographically selected patients a few minutes before PCI? A randomized multicentre trial PRAGUE-8 Eur Heart J 29 2008 1495 1503 (Pubitemid 351881978)
27. G. Dangas, R. Mehran, G. Guagliumi, A. Caixeta, B. Witzenbichler, J. Aoki, J.Z. Peruga, B.R. Brodie, D. Dudek, R. Kornowski, L.E. Rabbani, H. Parise, and G.W. Stone Role of clopidogrel loading dose in patients with ST-segment elevation myocardial infarction undergoing primary angioplasty: results from the HORIZONS-AMI (harmonizing outcomes with revascularization and stents in acute myocardial infarction) trial J Am Coll Cardiol 54 2009 1438 1446